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Objective: Several ultrasound classifications for thyroid nodules were proposed but
their accuracy is still debated, since mainly estimated on cytology and not on histology.
The aim of this study was to test the diagnostic accuracy and the inter-classification
agreement of AACE/ACE-AME, American Thyroid Association (ATA), British Thyroid
Association (BTA), and Modena Ultrasound Thyroid Classification (MUT) that stratifies
malignancy risk considering also the clinician subjective impression.
Methods: A prospective study collecting thyroid nodule features at ultrasound and
histological diagnosis was conducted. Ultrasound features were collected following a
preformed checklist in candidates for surgery because of indeterminate, suspicious,
or malignant cytology. All the nodules, besides the cytologically suspicious one, were
blinded analyzed. MUT score was applied prospectively, and the others retrospectively.
Sensitivity, specificity, diagnostic cut-off value, and accuracy of each classification were
calculated. The overall agreement between classifications was tested by Bland-Altman,
and agreement between single nodule analysis by different classifications by Weighted
Cohen’s Kappa.
Results: In classifying a total of 457 nodules, MUT has the highest accuracy (AUC
0.808) and specificity (89%), followed by ATA and BTA, and finally by AACE/ACE-AME.
ATA, BTA, and MUT are highly interchangeable. Considering agreement between single
nodule analyses, ATA and BTA had the best (κ = 0.723); AACE/ACE-AME showed slight
agreement with BTA (κ = 0.177) and MUT (κ = 0.183), and fair agreement with ATA (κ =
0.282); MUT had fair agreement with both ATA (κ = 0.291) and BTA (κ = 0.271).
Conclusion: Classifications have an acceptable overall diagnostic accuracy, improved
using a less rigid system that takes into consideration operator subjective impression.
Keywords: ultrasound, thyroid nodules, classifications, malignancy risk, histology
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INTRODUCTION
The leading role of ultrasound (US) in thyroid nodules evaluation
is now well stated and accepted. However, no single US feature
was proven to be unequivocally predictive of benignity or
malignancy and to provide reliable information to categorically
select nodules that should undergo fine needle aspiration
(FNA) (1). Consequently, only the combination of different
US characteristics can identify nodules with an increased risk
for malignancy.
Recent meta-analyses demonstrated that clinical studies failed
to identify US features that, alone or in combination, are certainly
indicative of malignancy or benignity (1–3). The highest odds
ratio for malignancy was found for taller than wide shape,
microcalcifications, irregular margins, and absence of elasticity
or halo sign. On the other hand, only cystic content and
spongiform appearance seem to predict benign nodules. A
remarkable heterogeneity across studies was detected, increasing
the likelihood of bias and reducing the reliability of the estimated
diagnostic accuracy.
Several US classifications have been proposed with the aim
to provide a useful tool for both clinicians and researchers (4–
17). More recently, the AACE/ACE-AME Task Force on thyroid
nodules (15) reviewed and compared classifications adopted by
the American Thyroid Association (ATA) in 2015 (16) and by
the British Thyroid Association (BTA) in 2014 (17), offering a
new proposal weighted on current scientific evidence. Eventually,
a three-class rating system was proposed, distinguishing low,
intermediate, and high-risk lesions (15). Moreover, they suggest
to complete US reports with a rating that stratifies nodules based
on their malignancy risk (15).
In order to have an orientation in this maze of classifications,
some studies recently compared their predictive value of
malignancy (18–21). However, results are not univocal, and
accuracy has almost always been estimated considering nodule
cytology and only rarely, moreover retrospectively, final
histological diagnosis (22). Moreover, clinical practice and some
studies suggested that most of these systems are not always easily
applicable, due to their intrinsic low flexibility. For example, up
to 5% of nodules do not match any sonographic pattern proposed
by ATA and remain in a gray area (14, 18, 19).
Before the risk stratification systems mentioned above were
published, we set up a local classification, based on the existing
literature on the predictive US characteristics of malignancy.
This tool named Modena US Thyroid Classification (MUT)
considers, in the last instance, also the subjective impression of
the clinician for differentiating low-risk from high-risk thyroid
nodules, based on his/her own clinical experience with the aim
to add information especially for those nodules with uncertain
categorization due to US characteristics within the above-
mentioned gray area.
The aim of the present study was to test the diagnostic
accuracy of different thyroid US classification systems (ATA,
AACE/ACE-AME, BTA, and MUT) and to evaluate inter-
classification agreement by using histological outcomes as term
of comparison. In particular, the effect of the operator judgment
in the MUT classification and the histological outcome represent
novelty with respect to previous studies comparing different US
classifications of thyroid nodules.
METHODS
Study Design
From November 2008 to April 2015, we prospectively enrolled
patients who underwent US-guided FNA with a cytological
diagnosis of indeterminate (TIR3), suspicious for malignancy
(TIR4), or malignant (TIR5) lesion, according to the Italian
Consensus for the cytological classification of thyroid nodules
(23), on one or more thyroid nodules. The samples collected
before the use of this classification have been revised and
a specific cytological category was assigned. Each cytological
sample was analyzed by expert physicians, in the same
Pathology laboratory.
We selected 111 patients with the following inclusion criteria:
age above 18 years; indication for thyroid surgery accordingly to
a cytological diagnosis of TIR3 or TIR4 or TIR5 on at least one
thyroid nodule.
All the enrolled patients underwent neck US before surgery
with the purpose of carefully describing each nodule and explore
neck region lymph nodes. US examination was performed using
a checklist (Figure 1) for collecting each US feature in detail
(see section US examination). When multinodular goiter was
present, each nodule, in addition to the one subjected to FNA,
was carefully described, following the listed items, and mapped
in relation to its position within thyroid making the comparison
with histology possible. In particular, the precise position of each
nodule in the lobes or isthmus was recorded. During the exam,
the endocrinologist classified each nodule on the basis of US
features and his own impression in five categories (MUT 1–
5), detailed below (see section US classifications). After US, all
the enrolled patients underwent total thyroidectomy, with or
without lymph nodes dissection based on clinical indication. For
each nodule, we therefore obtained a histological confirmation
and exhaustive description of its location. Thus, the histological
report was examined to match the US description with the final
diagnosis for each nodule, thanks to the detailed information
about nodules position in both reports.
Finally, we retrospectively classified all the US scanned
nodules according to AACE/ACE-AME, ATA, and BTA
classification systems.
The study was approved by the local ethical committee
“Comitato etico provinciale di Modena,” and all participants
signed an informed consent.
US Examination
US scans were performed with Siemens Acuson Antares R©
(Philadelphia, USA, 10 MegaHertz-linear scanner, B mode) by
a single expert endocrinologist, with 10 years of thyroid US
experience at study baseline, aware of the presence of a suspect
nodule. In each patient, nodules were described, regardless of
their cytological diagnosis, for a total of 457 lesions (see section
Results for details) and specific features were collected in a
preformed checklist (Figure 1). In order to reduce errors, all
the data collected were recorded in real time, reducing the risk
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FIGURE 1 | Preformed checklist used for the collection of nodules features during ultrasound examination.
of forgetting the analysis of some US feature. In other words,
the checklist obliged the operator to check all the itemized US-
features for each nodule (Figure 1).
The following US features were considered: nodule
localization (position in the right lobe/left lobe/isthmus),
size, shape, calcifications, echogenicity, margins, composition,
vascular pattern, and the presence of uninodular or multinodular
goiter. In particular, size was described with 3 diameters:
antero–posterior, transverse, and longitudinal (reported in
mm). Shape was considered as a tall/wide ratio >1 or <1. The
presence or absence of calcifications was described as follows:
microcalcifications (<2mm), macrocalcifications (>2mm),
eggshell calcification, coarse calcifications. The ultrasound
echogenicity was defined compared to the surrounding
parenchyma as: hyperechoic, isoechoic, hypoechoic, or markedly
hypoechoic (compared to muscle echogenicity). Margins were
described as regular or irregular (including microlobulated,
speculated, and infiltrative). The presence or the absence
of a peripheral hypoechoic halo was specified. Considering
composition, we described nodules as solid, cystic, or mixed.
Vascularization was measured by color-Doppler and indicated as
absent, peripheral, or intranodular.
US Classifications
During US scan, performed after the suspect cytological result
and before surgery, the endocrinologist classified each nodule
according to MUT classes: MUT1, unclear nodular lesion
(e.g., pseudonodular appearance in Hashimoto thyroiditis);
MUT2, nodule without features suspicious for malignancy
(cystic or spongiform appearance); MUT3, indeterminate
nodule (nodular lesion not attributable to MUT2, MUT4,
or MUT5 categories); MUT4, suspect nodule (with at least
one of microcalcifications, irregular margins, hypoechogenicity,
intranodular vascularization, tall/wide ratio > 1, incomplete
eggshell calcification with extension to soft tissue, clear
extrathyroid extension); MUT5, very suspect nodule (with one
or more of the features listed for MUT4, and considered strongly
suspect according to operator’s judgment). These categories were
defined using the structure of the Italian Consensus for the
thyroid nodules cytological classification (23) as amodel, in order
to make its use and interpretation easier. Specifications of each
of the five categories were defined according to the knowledge
present in the literature, leaving the US operator the possibility to
rule on the nodule category risk based on his ultrasound-clinical
experience. Starting from the concept that there is inter-observer
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and intra-observer variability in interpreting US characteristics
and that available US classifications do not cover all US
characteristics (24, 25), the operator was asked to downgrade or
upgrade the class of risk in presence of its judgment based also
on clinical (not US) data available and on his advisory opinion
arising from his/her US series of experience.
In addition, thanks to the detailed collection of each nodule
US features on the preformed checklist, we were able to assign a
category risk according to AACE/ACE-AME, ATA, and BTA US
classification systems (15–17).
In summary, AACE/ACE-AME classification includes
the following risk classes: low-risk (AACE/ACE-AME 1),
intermediate-risk (AACE/ACE-AME 2), and high-risk
(AACE/ACE-AME 3) lesions (15). The ATA classification
discriminates among the following categories: benign, purely
cystic nodules (ATA1); very low suspicion nodules without
any of the US features described in low-, intermediate-,
or high-suspicion patterns (ATA2); low suspicion (ATA3);
intermediate suspicion (ATA4); high suspicion (ATA5)
(16). The BTA classification recommends the following five
categories: normal thyroid tissue (BTA1); benign nodules
(BTA2); indeterminate/equivocal nodules (BTA3); suspicious
nodules (BTA4); malignant nodules (BTA5) (17).
Statistical Analysis
The Cohen’s kappa (κ) statistic was used to measure the
agreement between measurements of the classification systems.
We selected κ statistic as the measure of agreement because our
variable of interest is categorical (26, 27). Kappa is a measure
of this difference, standardized to lie on a −1 to 1 scale, where
1 is perfect agreement, 0 is exactly what would be expected by
chance, and negative values indicate agreement less than chance,
i.e., potential systematic disagreement between the observers.
The interpretation of agreement adopted here is less than chance
agreement (κ = 0), slight agreement (κ = 0.01–0.20), fair
agreement (κ = 0.21–0.40), moderate agreement (κ = 0.41–
0.60), substantial agreement (κ = 0.61–0.80), and almost perfect
agreement (κ = 0.81–0.99).
The diagnostic performance is evaluated on the receiver
operating characteristic (ROC) curve and the area under the
curve (AUC). A ROC curve describes the relationship between
the sensitivity and specificity of a test by plotting the two against
one another while varying the evaluation, which determines the
outcome of a test. The two are inversely related, as one increases
the other decreases. Conventionally, since both values range
between 0 and 1, the sensitivity (true positive rate) is plotted
against 1 minus the specificity (false positive rate). The plot is,
therefore, in essence, a representation of the tradeoff between
detecting true and false positive cases. Cut-off was calculated
for each classification and then used to compare the rankings
with the histological diagnosis. Moreover, Bland-Altman analyses
were used to validate agreement between the four measurements
of the classification systems. The Bland–Altman scatter plot
represents the relationship between the values of the differences
of two measurements of the same nature (y-axis) and their
mean (x-axis), indicating the line relative to the average of the
differences of the two measurements± 2 standard deviation.
For all analyses, a p < 0.001 was considered statistically
significant. MedCalc Statistical Software version 14.8.1 (MedCalc
Software bvba, Ostend, Belgium; http://www.medcalc.org; 2014)
and STATA program version 14 (StataCorp LP 4905 Lakeway
Drive College Station, Texas 77845, USA) were used to perform
statistical analysis.
RESULTS
A total of 111 patients (33 males, 78 females; mean age 51
years) were enrolled in the study. Fifteen subjects had uninodular
goiter and 96 were affected by multinodular goiter. In the latter,
all 442 nodules were US evaluated and classified. Considering
solitary and multiple nodules together, a total of 457 nodules
were analyzed. Cytological characteristics and malignancy rate at
histology are summarized in Table 1.
Overall, histological examination revealed 323 benign nodules
(71%) and 134 malignant nodules (29%), comprising 80 classic
papillary carcinomas, 4 cystic papillary carcinomas, 29 follicular
variants of papillary carcinoma, 5 oncocytic papillary carcinomas,
6 follicular carcinomas, 2 Hurthle cells carcinomas, 1 insular
carcinoma, and 7 medullary carcinomas.
Thanks to a detailed description of nodule position, it was
possible to establish the correspondence between sonographic
appearance, cytology, and histology for each lesion. Nodules
distribution according to the four studied classification systems
is shown in Figure 2, together with the percentage of benign or
malignant lesions for each category. As expected, malignancy
rate increases in each category with increasing risk class, with
only one deviation in category 4 of ATA and BTA. In this
case, malignancy rate is reduced compared to previous category,
TABLE 1 | Characteristics of the analyzed thyroid nodules.
Solitary nodules Nodules in
(n = 15) multinodular goiter
(n = 442)
Analyzed by FNA 15/15 (100%) 156/442 (35%)
Cytology*
TIR1 0 21 (13%)
TIR2 0 29 (19%)
TIR3 3 (20%) 40 (26%)
TIR4 5 (33%) 42 (27%)
TIR5 7 (47%) 24 (15%)
Histology
Malignancy rate 14/15 (93%) 103/156 (66%)
Not analyzed by FNA 0 286/442 (65%)
Histology
Malignancy rate n.a. 17/286 (6%)
Cytological classification was available only for nodules that underwent fine needle
aspiration (FNA). Malignancy rate was calculated considering histological diagnosis for
each nodule, after surgery.
*According to “Italian Consensus for the cytological classification of thyroid nodules” (23):
TIR1, non-diagnostic; TIR2, negative for malignant cells; TIR3, inconclusive/indeterminate;
TIR4, suspicious for malignancy; TIR5, diagnostic of malignancy. n.a., not applicable.
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FIGURE 2 | Nodules distribution according to AACE/ACE-AME Task Force on thyroid nodules, American Thyroid Association (ATA), British Thyroid Association (BTA),
and Modena US Thyroid Classification (MUT). Benignity and malignancy have been diagnosed histologically according to histology. Numbers in bars are expressed as
percentage of the total number of nodules for each category.
suggesting a reduction in specificity, confirmed below in our
subsequent analyses. Considering the highest risk class for each
classification, malignancy rate was between 41 and 50% in ATA,
AACE/ACE-AME, and BTA, and highest (92%) only in MUT.
Among the 134 malignant nodules, 34 were in the context of a
multifocal neoplasia. Only 78 were expected from cytology (TIR4
or TIR5), while 56 were unexpectedly diagnosed.
The ROC curve analysis demonstrated that MUT
classification system has the highest AUC, followed by ATA,
BTA, and finally, AACE/ACE-AME (Figure 3). Sensitivity,
specificity, AUC, and the cut-off to better predict the risk of
malignancy for each classification are shown in Table 2. In
particular, the analysis indicated that categories above two for
AACE/ACE-AME, above three for MUT, and above four for
ATA and BTA are the best to predict malignancy risk, having the
best combination of sensitivity and specificity.
The quantification of the overall agreement between
classifications by Bland-Altman test showed that: (i) AACE/ACE-
AME is the least interchangeable with all the other three
classification systems (Figures 4A,D,E), (ii) MUT is comparable
to both ATA and BTA (Figures 4B,C), and (iii) ATA and BTA are
highly interchangeable (Figure 4F).
Finally, the agreement between single nodule analyses by
different classifications was evaluated considering Weighted
Cohen’s Kappa (Table 3). ATA and BTA had the best agreement
(κ = 0.723). AACE/ACE-AME showed slight agreement with
BTA (κ = 0.177) and MUT (κ = 0.183), and fair agreement with
FIGURE 3 | ROC curve that describes the relationship between the sensitivity
and specificity of the four classification systems [AACE/ACE-AME Task Force
on thyroid nodules, American Thyroid Association (ATA), British Thyroid
Association (BTA), and Modena US Thyroid Classification (MUT)].
ATA (κ = 0.282). Finally, MUT had fair agreement with both
ATA (κ = 0.291) and BTA (κ = 0.271).
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DISCUSSION
The results of the present study demonstrate that US operator
subjective impression has a not negligible role in defining the
TABLE 2 | ROC curve analysis for the different classification systems.
Sensitivity Specificity AUC* Cut-off
AACE/ACE-AME 83 48 0.666 >2
ATA 74 68 0.731 >4
BTA 83 58 0.718 >4
MUT 62 89 0.808 >3
AACE/ACE-AME Task Force on thyroid nodules, American Thyroid Association (ATA),
British Thyroid Association (BTA), and Modena US Thyroid Classification (MUT), *AUC,
area under the curve.
risk of malignancy of a thyroid nodule. In fact, when a system
like MUT is used, the highest accuracy is reached, overcoming
ATA, BTA, and AACE/ACE-AME classifications. Moreover,
MUT has high specificity, maintaining good sensitivity. This
result suggests that the operator subjective impression, resulting
from US technique knowledge and clinical experience, has
a considerable impact on US accuracy. Thus, objective US
findings need to be critically processed by the operator, who
can re-weight the risk with respect to what is established
by the classification system alone. Thus, in the clinical daily
life thyroid US remains a subjective imaging tool that holds
the operator expertise as an intrinsic characteristic of this
instrument (24, 25).
From a practical point of view, nodules considered as suspect
or very suspect (MUT class 4 or 5) by the US operator need
to undergo FNA, since the malignancy risk is of 63 and
FIGURE 4 | Bland–Altman plots showing the differences between measurements of the classification systems. The blue line is the average of the differences (in case
the first and second measurements were coincidentally, points would be aligned along the axis of the abscissas and positioned on the value 0); the dot lines are the
95% limits of agreement. (A) MUT vs. AACE/ACE-AME; (B) MUT vs. ATA; (C) MUT vs. BTA; (D) AACE/ACE-AME vs. ATA; (E) AACE/ACE-AME vs. BTA; (F) ATA vs.
BTA [AACE/ACE-AME Task Force on thyroid nodules, American Thyroid Association (ATA), British Thyroid Association (BTA), and Modena US Thyroid Classification
(MUT)].
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TABLE 3 | Frequencies, κ-value, significance and reproducibility of the different measurement of classification systems are illustrated.
MUT κ Significance
ATA 1 2 3 4 5 0.291 Fair agreement
1 0 56 3 0 0
2 1 7 42 1 0
3 0 7 54 2 0
4 0 3 73 3 0
5 6 6 79 88 26
BTA 0.271 Fair agreement
1 0 0 0 0 0
2 1 67 55 2 0
3 1 1 23 2 0
4 0 3 54 1 0
5 5 8 119 89 26
AACE/ACE/AME 0.183 Slight agreement
1 0 57 24 1 0
2 1 16 77 2 0
3 6 6 150 91 26
AACE/ACE-AME
ATA 1 2 3 0.282 Fair agreement
1 59 0 0
2 16 34 1
3 7 51 5
4 0 3 76
5 0 8 197
BTA 0.177 Slight agreement
1 0 0 0
2 70 53 2
3 10 9 8
4 0 0 58
5 2 34 211
ATA
BTA 1 2 3 4 5 0.723 Substantial agreement
1 0 0 0 0 0
2 59 40 25 0 1
3 0 10 14 0 3
4 0 0 0 52 6
5 0 1 24 27 195
The interpretation of agreement is: less than chance (κ = 0), slight (κ = 0.01–0.20), fair (κ = 0.21–0.40), moderate (κ = 0.41–0.60), substantial (κ = 0.61–0.80), or almost perfect
agreement (κ = 0.81–0.99).
AACE/ACE-AME Task Force on thyroid nodules, American Thyroid Association (ATA), British Thyroid Association (BTA), and Modena US Thyroid Classification (MUT).
90%, respectively. Whereas cytological investigation must be
considered in nodules classified as AACE/ACE-AME 3, ATA 5,
or BTA5.
Then, we evaluated the interchangeability between
classifications and the degree of agreement in the evaluation of
each single nodule. MUT differs from ATA and BTA, which are
highly exchangeable and mostly in agreement with each other.
AACE/ACE-AME is the one that differs most from all the others,
probably also as a consequence of its peculiar structure that
provides only three classes instead of five. In conclusion, we think
that a classification that considers the operator’s subjectivity
is inevitably different from the others, but in the end leads to
better accuracy.
The main limit of guidelines proposed by international
societies derives from the lack of specificity, mostly at
highest categories. In fact, we confirm that they all have
high sensitivity but low specificity (18, 21, 28). Accordingly,
malignancy rate remains between 41 and 50% even in the
highest risk class, with possible consequent over-medicalization
and unnecessary FNA. In particular, our results show a much
lower percentage than that expected for ATA classification.
Guidelines and following studies indicate a malignancy rate
above 70% for ATA high suspicion lesions (16, 21, 28). On
the contrary, our results agree with recently published data,
demonstrating a positive predictive value of 28% (29) and a
malignancy rate of 55% (18) in ATA highest risk class. Even
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Lauria Pantano et al. (19) found a lower rate of malignancy
within ATA high-suspicion (35.6%) and AACE/ACE-AME
class 3 (19.8%) compared to what was expected. Finally, a
considerable unnecessary FNA rate was demonstrated for the
highest category of both ATA (52%) and AACE/ACE-AME
(32%) (21).
It must be here emphasized that guideline classifications
have been proposed as a careful and reasoned outcome of the
scientific literature. However, the use of rigid rating systems is
not always easy in real clinical life because of the nearly endless
number of US feature combinations. Sometimes the clinician
struggles to enter the lesion in a class rather than another,
because of intermediate or ambiguous situations (14, 18, 19, 25).
Moreover, interobserver agreement has recently been questioned
in a multicenter study, resulting lower than that suggested by
single center studies (24). Finally, it is possible that a nodule
is classified in a category that does not match the one in
which the clinician would have classified it according to his/her
experienced-based perception.
We think that the present study has several strengths: all
the US examinations were performed by the same expert
endocrinologist, who prospectively evaluated patients with
indeterminate or suspect FNA results; detailed and systematic
collection of sonographic findings was compiled for each nodule,
making the information available for a subsequent, retrospective,
application of other classifications; the availability of histological
diagnosis allowed to calculate the real diagnostic accuracy of each
US risk class; in multinodular goiter, all the nodules, not only
the ones addressed to FNA, were US evaluated and correlated
with histological outcome, representing a good sample to test
classifications performance.
However, some limitations must be listed. First of all,
subjective impression is by definition difficult to quantify and
classify. MUT is just an example, used as a tool to blow up the
importance of subjectivity. Then, US performer was aware of the
presence of a suspect nodule in the examined thyroid, which
may have affected his judgment, especially in solitary nodules.
Moreover, it is likely that our result is affected by a selection
bias due to the fact that all the selected solitary nodules were
cytologically indeterminate or suspect and already addressed
to surgery. Lastly, the retrospective assignment to AACE/ACE-
AAME, ATA, and BTA categories does not allow the evaluation
of the operator compliance with their use nor the unavoidable
inter-operator variability in US interpretation (30). The presence
of a single operator ensures judgment homogeneity, but at the
same time it avoids any inter-observer evaluation, making the
use of MUT not generalizable. Further studies will be needed for
this purpose.
In clinical practice, the present study suggests that the “human
brain factor,” meaning the overall impression of the US operator,
is of value to better stratify malignancy risk after having applied
a US classification. Secondly, we confirm that the use of one of
the available classifications must be encouraged since it helps
to correctly address risky nodules to FNA (22). Since most
of them are highly interchangeable, it does not matter which
one is used, but the operator must be aware of its limits and
compensate with his/her subjective impression. US operator
should also keep in mind that US classifications are targeted to
differentiated thyroid carcinoma and may fail in identifying the
most worrisome subtypes of thyroid cancer, such as the anaplastic
one, presenting different and misleading US-appearances (31).
The results of this study suggest that the operator have to embrace
one of the available US classifications in clinical practice, but
he/she should bear in mind that these classifications do not cover
the wide umbrella of heterogeneous characteristics of thyroid
nodules since they operate by simplification within each US
category and that inter- and intra-observer differences in the
interpretation of US characteristics exist. Thus, the US operator
may avoid to rigidly categorize the nodule according the rigid
criteria of the classification especially when the characteristics of
the nodule do not clearly fit with these criteria. By reconverting
the US category according to the self-judgment of the operator,
in fact, may improve the diagnostic accuracy of US, especially
in case of operator with a great experience in thyroid US.
However, the presence of a highly experienced US-physician
is not guaranteed in low-volume thyroid centers, where the
application of classification could represent a useful and effective
first approach.
In conclusion, our findings suggest the good diagnostic
performance of US classifications, corroborating the thesis in
favor of their usefulness in clinical life. But accuracy improves
when the subjective impression of the clinician is considered
too. In this sense, the inescapable subjectivity of the sonographic
description is no more a limit, but it could be an added value
for the endocrinologist, who is able to integrate the guidelines
derived ranking with his/her experienced-based perception.
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